Mirtazapine for Sleep, Mood, and PTSD
Mirtazapine can be used for depression with prominent sleep disturbances, but it is NOT a first-line treatment for PTSD and should not be used as monotherapy for PTSD based on the highest quality evidence.
Depression and Sleep
Mirtazapine is FDA-approved for major depressive disorder at 15-45 mg daily, starting at 15 mg at bedtime 1. The drug label specifically recommends evening dosing, which aligns with its sedating properties 1.
For depression specifically:
- Mirtazapine has a faster onset of action than SSRIs (fluoxetine, paroxetine, sertraline) 2
- It is particularly useful when sleep disturbance is a prominent feature of depression
- The typical effective dose range is 15-45 mg, with dose adjustments made no more frequently than every 1-2 weeks 1
Important caveat: Lower doses (15 mg) are often MORE sedating than higher doses due to mirtazapine's unique pharmacology—at lower doses, antihistamine effects predominate, while at higher doses, noradrenergic effects become more prominent.
PTSD Treatment
The evidence for mirtazapine in PTSD is weak and contradictory:
Against Use as Monotherapy:
- The highest quality RCT (2020) with 78 veterans showed NO significant benefit on the primary outcome (Structured Interview for PTSD) compared to placebo 3
- A 2022 network meta-analysis found only very low to low certainty evidence, with mirtazapine showing no clear benefit over placebo for sleep quality in PTSD 4
- Current PTSD treatment algorithms (2024-2025) do not include mirtazapine in their core recommendations 5
Limited Supporting Evidence:
- One small pilot study (n=26) from 2003 showed some benefit 6
- An open-label study (n=13 completers) suggested possible effectiveness but lacked placebo control 7
- A 2026 meta-analysis suggests mirtazapine may have potential as augmentation (not monotherapy) for PTSD 8
Real-World Practice:
Despite lack of guideline support, mirtazapine is commonly prescribed off-label for PTSD (21% of patients at discharge in one Swiss study), though this practice is not evidence-based 9.
Clinical Algorithm
For Depression with Sleep Disturbance:
- Start mirtazapine 15 mg at bedtime
- If inadequate response after 1-2 weeks, increase to 30 mg
- Maximum dose 45 mg if needed
- Screen for bipolar disorder before initiating 1
For PTSD:
- First-line: SSRIs (sertraline or paroxetine) per FDA approval and guidelines 5
- For PTSD-related insomnia specifically: Prazosin is first-line 5
- If considering mirtazapine: Only as augmentation to an SSRI, not as monotherapy
- Do NOT use mirtazapine as sole treatment for PTSD based on the 2020 RCT failure 3
Critical Warnings
- Screen for bipolar disorder before starting—mirtazapine can trigger mania 1
- Increased suicide risk in patients under 24 years old 1
- Weight gain is common—all subjects in one PTSD study gained weight, with one gaining 8.75 kg 7
- Metabolic effects: Monitor fasting glucose and lipids; one patient developed diabetes (FBG increased from 83 to 155 mg/dL) 7
- Taper gradually when discontinuing to avoid withdrawal symptoms 1
- Allow 14 days between stopping MAOIs and starting mirtazapine, and vice versa 1
Drug Interactions
Adjust dosing with: